Bobbi Jo Allen was exercising when she felt a lump on her neck.
Five years later, the Kentucky woman was diagnosed with stage 4 large B-cell non-Hodgkin's lymphoma, which typically responds well to chemotherapy, per a press release from the University of Kentucky Markey Cancer Center.
She was given doxorubicin, "one of the strongest and most toxic chemotherapies on the market," she says.
For eight months, she was treated with the drug, which is sometimes called "red devil chemotherapy" because of its red color and strong side effects.
After several months of treatment, she was diagnosed with remission, but in July 2023, Allen was told she had cancer again and would need a bone marrow transplant.
"I kept questioning the diagnosis at first," she says.
"They said the only treatment they could offer me was a bone marrow transplant.
I thought I could handle chemotherapy again, but a bone marrow transplant."
She spent the rest of the summer and fall getting ready for the transplant, working with a nutritionist to make sure she was gaining the right amount of weight and muscle.
Finally, on Jan.
24, 2024, Allen received the transplant.
"My immune system was totally wiped out," she says.
"I had nothing to protect
A customized collection of grant news from foundations and the federal government from around the Web.
Textbooks for Change, a London-based social enterprise that has obtained the B Corporation seal for positive social and environmental impact, is seeking investors that would be helping the company expand.